Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the official opening of the initial clinics at the Magrabi Hospital. Dr. Ibrahim Al-Omar, Undersecretary of the Ministry of Health for Investment, inaugurated last Wednesday the early detection unit… Continue reading Diagnos $ADK $DGNOF Announces the Opening of the #AI Assisted #Screening #Clinic at #Magrabi #Hospital with the Presence of the Undersecretary of the Ministry of #Health of #SaudiArabia
Tag: AI technology
Diagnos $ADK Announces a Pilot with Hospital Oftalmologico Buena Vista Sinaloa
Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), BROSSARD, Quebec, June 09, 2021 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, announces today the signing of a 2-month pilot with Hospital Oftalmológico Buena… Continue reading Diagnos $ADK Announces a Pilot with Hospital Oftalmologico Buena Vista Sinaloa
Diagnos Inc. $ADK AI Image-Based Diagnosis – Commercializing their CARA #Technology
Expanding globally in the AI image based diagnosis sector, Diagnos is actively commercializing their CARA technology. Diagnos TSXV-ADK is an AI health care company using non-invasive scanning technology done through the eyeball to detect retinal diabetes and hypertension. They are FDA approved, ISO certified and Health Canada approved. https://investorintel.com/markets/biotech-healthcare/biotech-intel/expanding-globally-in-the-ai-image-based-diagnosis-sector-diagnos-is-actively-commercializing-their-cara-technology/